Essendon Royals is privileged to be able to send 5% of all of our sponsorship revenue to 2 charities AMDF (Australian Mitochondrial Disease Foundation) and BCNA (Breast Cancer Network). Our members and sponsors wholeheartedly support this. We are here for the community and the power is in us to contribute positively in every way we can to our community life. By helping charities, Royals and sponsors execute on that power.
If anyone would like to help with these 2 charities, please contact Adam Maltese.
Australian Mitochondrial Disease Foundation (AMDF)
AMDF seeks to be the pre-eminent source of energy and hope for the mito community. AMDF supports the mito community whilst seeking a cure.
The AMDF was founded as a not for profit organisation in 2009 by Doug and Margie Lingard, their friends, and experts in the field of mitochondrial disease (mito). Doug and Margie tragically lost their son to mito, and their daughter, Rose, passed away from mito in 2017.
For the last 2 years we have held a charity day on behalf of the Essendon Royals Past and Present Players, Committee and Supporters where all money raised goes to the Australian Mitochondrial Disease Foundation. It’s a great day and we hope that more of our present-day members come down and get involved.
Breast Cancer Network Australia (BCNA)
BCNA is the peak national organisation for Australians affected by breast cancer, and consists of a network of more than 120,000 members and 288 Member Groups. More than 90 per cent of our members have had a diagnosis of breast cancer, and the remaining members have had a personal experience with breast cancer through a family member or friend.
We are represented by the Pink Lady silhouette, symbolic of our focus on the women diagnosed with breast cancer and all those around them.
For more information visit the BCNA website
We will also be holding another day yet to be confirmed where all money raised will go to the Breast Cancer Network of Australia with a Pink Sports Day where our senior teams will be kitted out in all pink.